Real-life Treatment Outcomes of Ravulizumab in PNH

NCT06633536 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Haemoglobinuria

Interventions

DRUG: Ravulizumab

Sponsor

AstraZeneca